l-Sulpiride, at a low, non-neuroleptic dose, prevents conditioned fear stress-induced freezing behavior in rats - PubMed

l-Sulpiride, at a low, non-neuroleptic dose, prevents conditioned fear stress-induced freezing behavior in rats

E Cavazzuti et al. Psychopharmacology (Berl). 1999 Mar.

Abstract

Antidepressant drugs are effective in anxiety states, including panic disorder. Both clinical and animal studies indicate that l-sulpiride, at low, non-neuroleptic doses, has antidepressant activity. The present study examined the effect of an antidepressant dose of l-sulpiride (4 mg/kg per day SC), compared with a well-established antidepressant drug (fluoxetine, 3 mg/kg per day SC), in a rat model of anticipatory anxiety/panic behavior: conditioned fear stress-induced freezing behavior. Long-term (26 days) administration of l-sulpiride almost completely abolished freezing, a similar effect being produced by fluoxetine (freezing duration, in seconds: controls, 148.1 +/- 29.6; l-sulpiride, 27.5 +/- 8.3; fluoxetine, 72.0 +/- 15.2). The same doses of l-sulpiride (4 mg/kg SC) and fluoxetine (3 mg/kg SC) had no effect when administered for shorter periods (1, 5, or 12 days). No effect was produced by the long-term (26 days) administration of a neuroleptic dose of l-sulpiride (20 mg/kg per day SC). These results demonstrate that long-term administration of low, non-neuroleptic doses of l-sulpiride, is highly effective in an animal model of anticipatory anxiety/panic behavior.

Similar articles

• L -sulpiride, at antidepressant dosage, prevents conditioned-fear stress-induced gastric lesions in rats.

  Benelli A, De Pol A, Poggioli R, Cavazzuti E, Arletti R, Bertolini A, Vergoni AV. Benelli A, et al. Pharmacol Res. 2000 Aug;42(2):157-60. doi: 10.1006/phrs.2000.0668. Pharmacol Res. 2000. PMID: 10887045

• The effects of the co-administration of the α₁-adrenoreceptor antagonist prazosin on the anxiolytic effect of citalopram in conditioned fear stress in the rat.

  Takamura N, Masuda T, Inoue T, Nakagawa S, Koyama T. Takamura N, et al. Prog Neuropsychopharmacol Biol Psychiatry. 2012 Oct 1;39(1):107-11. doi: 10.1016/j.pnpbp.2012.05.017. Epub 2012 May 30. Prog Neuropsychopharmacol Biol Psychiatry. 2012. PMID: 22658980

• [Effects of methamphetamine on responsiveness to conditioned fear stress].

  Tsuchiya K. Tsuchiya K. Hokkaido Igaku Zasshi. 1999 Jan;74(1):41-52. Hokkaido Igaku Zasshi. 1999. PMID: 10331059 Japanese.

• [A behavioral and neurochemical study on the mechanism of the anxiolytic effect of monoamine oxidase inhibitors].

  Maki Y. Maki Y. Hokkaido Igaku Zasshi. 2001 May;76(3):133-42. Hokkaido Igaku Zasshi. 2001. PMID: 11481866 Review. Japanese.

Cited by

• Sulpiride and refractory panic disorder.

  Nunes EA, Freire RC, Dos Reis M, de Oliveira E Silva AC, Machado S, Crippa JA, Dursun SM, Baker GB, Hallak JE, Nardi AE. Nunes EA, et al. Psychopharmacology (Berl). 2012 Sep;223(2):247-9. doi: 10.1007/s00213-012-2818-6. Epub 2012 Aug 5. Psychopharmacology (Berl). 2012. PMID: 22864966 No abstract available.

• Fluoxetine protects hippocampal plasticity during conditioned fear stress and prevents fear learning potentiation.

  Spennato G, Zerbib C, Mondadori C, Garcia R. Spennato G, et al. Psychopharmacology (Berl). 2008 Mar;196(4):583-9. doi: 10.1007/s00213-007-0993-7. Epub 2007 Nov 9. Psychopharmacology (Berl). 2008. PMID: 17992518

• Aniracetam: its novel therapeutic potential in cerebral dysfunctional disorders based on recent pharmacological discoveries.

  Nakamura K. Nakamura K. CNS Drug Rev. 2002 Spring;8(1):70-89. doi: 10.1111/j.1527-3458.2002.tb00216.x. CNS Drug Rev. 2002. PMID: 12070527 Free PMC article. Review.

• Chronic treatment with fluoxetine prevents the return of extinguished auditory-cued conditioned fear.

  Deschaux O, Spennato G, Moreau JL, Garcia R. Deschaux O, et al. Psychopharmacology (Berl). 2011 May;215(2):231-7. doi: 10.1007/s00213-010-2134-y. Epub 2010 Dec 22. Psychopharmacology (Berl). 2011. PMID: 21181120

• The effect of SSRIs on fear learning: a systematic review and meta-analysis.

  Heesbeen EJ, Bijlsma EY, Verdouw PM, van Lissa C, Hooijmans C, Groenink L. Heesbeen EJ, et al. Psychopharmacology (Berl). 2023 Nov;240(11):2335-2359. doi: 10.1007/s00213-023-06333-7. Epub 2023 Feb 27. Psychopharmacology (Berl). 2023. PMID: 36847831 Free PMC article. Review.

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Springer

• Medical

  • MedlinePlus Health Information